Drug Discovery Services
Outsourcing Your Drug Discovery Begins Here
Outsourcing of drug discovery efforts shorten development timelines by reducing the need to dedicate in-house resources to design and validate a multitude of assays. To fully assist drug discovery and development, Eurofins DiscoverX provides unique and proprietary assay solutions that span the entire drug discovery continuum and support both target-based and phenotypic discovery.
BioMAP® Phenotypic Services
In Vivo Insights with the Speed and Ease of an In Vitro Assay
BioMAP® Phenotypic Profiling Services
This service provides drug developers a simple, in vitro solution for gathering the most clinically relevant insights about efficacy and safety of a compound or lead molecule. With over 60 human primary cell-based models of tissue and disease biology, profile a compound‘s effects across 100’s of protein biomarkers and compare performance and mechanistic behavior to over thousands of reference compounds.
Learn More |
LeadHunter® Target-Based Services
The Broadest Cell-Based Functional Assay Coverage
PathHunter® Screening & Profiling Services
Over 700 cell-based assays that can be used in all stages of drug discovery from target validation and hit identification to lead optimization. The most comprehensive assay offering for over 9 target classes, such as GPCRs, and the fastest turnaround time in the industry.
Learn More |
|
The Broadest Kinome Coverage
KINOMEscan® Screening & Profiling Services
With the most comprehensive kinase assay menu and the fastest turnaround time, this service enables you to determine compound selectivity and potency at every step in your drug discovery process. Measure thermodynamic Kd values and analyze inter-kinase inhibitor SAR easily.
Learn More
|
Functional Data for Improved Off-Target Liability Testing
SAFETYscan™ In Vitro Pharmacological Profiling Services
Designed for lead optimization and safety profiling, SAFETYscan offers functional assays with human targets for safety screening, improving upon traditional rodent-based binding assays. Assess specificity of lead compounds early in development for more informed compound safety decision making.
Learn More
|
|
Comprehensive Panels for Selectivity, Safety Profiling, and Target Validation
LeadHunter® Drug Discovery Services Panels
With over 15 years of experience in Kinase and GPCR drug discovery, Eurofins DiscoverX offers the largest collection of biochemical and cell-based assays for screening compounds across selectivity and safety panels. LeadHunter Service panels expedite decision making during SAR in Lead Optimization.
Learn More
|
Building a Better Assay Together
Custom Assay Development Services
The Custom Assay Development program develops tailor-made cell lines optimized for your needs, enabling you to jump start your drug discovery programs. The cell-based assays created by our team help your program move faster and solve your difficult assay development challenges while saving you time, money, and resources.
Learn More
|
|
|
Services by Target Type
GPCR screening and profiling services
Learn More
Kinase screening and profiling services
Learn More
Checkpoint Receptor screening and profiling services
Learn More
Interleukin screening and profiling services
Learn More
Epigenetic screening and profiling services
Learn More
BCL2 screening and profiling services
Learn More
Nuclear Hormone Receptor (NHR) screening and profiling services
Learn More
Pathway Panel services
Learn More
Therapeutic Disease Panel services
Learn More
Resources
In Vitro Pharmacological Services Brochure
Download Brochure
Custom Assay Development Brochure
Download Brochure